文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

肥胖或超重患者拔管后无创通气的获益:一项随机临床试验的事后分析

Beneficial Effects of Noninvasive Ventilation after Extubation in Obese or Overweight Patients: A Post Hoc Analysis of a Randomized Clinical Trial.
PubMed 文献 · Am J Respir Crit Care Med · 2022-01-01
一句话结论肥胖或超重拔管失败高危患者拔管后预防性无创通气交替经鼻高流量氧疗,较单用经鼻高流量氧疗降低7天再插管率和ICU死亡率。

本文为多中心随机对照试验的事后分析(非预设),比较拔管后无创通气交替经鼻高流量氧疗与单用经鼻高流量氧疗,按体重指数评估无创通气效果。623例拔管失败高危患者中,肥胖206例(33%,BMI≥30 kg/m2)、超重204例(33%,25≤BMI<30 kg/m2)、正常或偏瘦213例(34%,BMI<25 kg/m2)。按BMI分层的无创通气对再插管率的影响存在显著异质性(交互作用P=0.007)。肥胖或超重患者中,无创通气交替经鼻高流量氧疗组第7天再插管率7%(15/204)显著低于单用经鼻高流量氧疗组20%(41/206),差值-13%(95%CI -19至-6;P=0.0002),而正常或偏瘦患者中无显著差异;肥胖或超重患者ICU死亡率2% vs 9%,差值-6%(95%CI -11至-2;P=0.006)。结论:肥胖或超重拔管失败高危患者拔管后立即预防性无创通气交替经鼻高流量氧疗可显著降低再插管和死亡风险;正常或偏瘦患者中无创通气无效。

要点

  • 肥胖或超重(BMI≥25 kg/m2)拔管失败高危患者,拔管后无创通气交替经鼻高流量氧疗较单用经鼻高流量氧疗第7天再插管率7%(15/204)vs 20%(41/206),差值-13%(95%CI -19至-6;P=0.0002)。
  • 同一人群中ICU死亡率无创通气组2% vs 单用经鼻高流量氧疗组9%,差值-6%(95%CI -11至-2;P=0.006)。
  • 按BMI分层的无创通气效果存在显著异质性(交互作用P=0.007)。
  • 正常或偏瘦(BMI<25 kg/m2)患者中,无创通气与单用经鼻高流量氧疗的再插管率无显著差异。
  • 623例拔管失败高危患者中肥胖206例(33%)、超重204例(33%)、正常或偏瘦213例(34%)。

适用人群与场景

  • 多中心随机对照试验纳入的623例ICU拔管失败高危患者,拔管后按体重指数分为肥胖206例(33%,BMI≥30 kg/m2)、超重204例(33%,25 kg/m2≤BMI<30 kg/m2)、正常或偏瘦213例(34%,BMI<25 kg/m2)。
  • 本分析为按体重指数评估无创通气效果的事后分析(非预设)。

诊断标准与关键阈值

  • 肥胖定义为BMI≥30 kg/m2;超重定义为25 kg/m2≤BMI<30 kg/m2;正常或偏瘦定义为BMI<25 kg/m2。

处置流程与药物剂量

  • 拔管后无创通气交替经鼻高流量氧疗,与单用经鼻高流量氧疗比较;原文未给出无创通气具体参数、给药方案或疗程。
  • 肥胖或超重拔管失败高危患者拔管后立即预防性使用无创通气交替经鼻高流量氧疗,可显著降低再插管和死亡风险(作者结论)。

研究设计与关键结果

  • 多中心随机对照试验的事后分析(非预设),623例拔管失败高危患者,比较拔管后无创通气交替经鼻高流量氧疗与单用经鼻高流量氧疗,按体重指数评估效果。
  • 按BMI分层的无创通气对再插管率的影响存在显著异质性(交互作用P=0.007)。
  • 肥胖或超重患者第7天再插管率:无创通气交替经鼻高流量氧疗组7%(15/204)vs 单用经鼻高流量氧疗组20%(41/206),差值-13%(95%CI -19至-6;P=0.0002)。
  • 正常或偏瘦患者中,无创通气交替经鼻高流量氧疗与单用经鼻高流量氧疗的再插管率无显著差异。
  • 肥胖或超重患者ICU死亡率:无创通气组2% vs 单用经鼻高流量氧疗组9%,差值-6%(95%CI -11至-2;P=0.006)。

证据类型、等级与局限

  • 证据类型:多中心随机对照试验的事后分析(非预设)。
  • 临床试验注册号:NCT03121482。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,肥胖或超重拔管失败高危患者拔管后立即预防性无创通气交替经鼻高流量氧疗,较单用经鼻高流量氧疗可显著降低再插管和死亡风险。
  • 作者认为,正常或偏瘦患者中无创通气无效。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Rationale: Although noninvasive ventilation (NIV) may prevent reintubation in patients at high risk of extubation failure in ICUs, this oxygenation strategy has not been specifically assessed in obese patients. Objectives: We hypothesized that NIV may decrease the risk of reintubation in obese patients compared with high-flow nasal oxygen. Methods:Post hoc analysis of a multicenter randomized controlled trial (not prespecified) comparing NIV alternating with high-flow nasal oxygen versus high-flow nasal oxygen alone after extubation, with the aim of assessing NIV effects according to patient body mass index (BMI). Measurements and Main Results: Among 623 patients at high risk of extubation failure, 206 (33%) were obese (BMI ⩾ 30 kg/m2), 204 (33%) were overweight (25 kg/m2 ⩽ BMI < 30 kg/m2), and 213 (34%) were normal or underweight (BMI < 25 kg/m2). Significant heterogeneity of NIV effects on the rate of reintubation was found according to BMI (Pinteraction = 0.007). Reintubation rates at Day 7 were significantly lower with NIV alternating with high-flow nasal oxygen than with high-flow nasal oxygen alone in obese or overweight patients: 7% (15/204) versus 20% (41/206) (difference, -13% [95% confidence interval, -19 to -6]; P = 0.0002), whereas it did not significantly differ in normal or underweight patients. In-ICU mortality was significantly lower with NIV than with high-flow nasal oxygen alone in obese or overweight patients (2% vs. 9%; difference, -6% [95% confidence interval, -11 to -2]; P = 0.006). Conclusions: Prophylactic NIV alternating with high-flow nasal oxygen immediately after extubation significantly decreased the risk of reintubation and death compared with high-flow nasal oxygen alone in obese or overweight patients at high risk of extubation failure. By contrast, NIV was not effective in normal or underweight patients. Clinical trial registered with www.clinicaltrials.gov (NCT03121482).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Thille AW, Coudroy R, Nay MA, et al. Beneficial Effects of Noninvasive Ventilation after Extubation in Obese or Overweight Patients: A Post Hoc Analysis of a Randomized Clinical Trial. Am J Respir Crit Care Med. 2022. PMID: 34813391. doi:10.1164/rccm.202106-1452OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。